DAPSONE FOR PREVENTION OF PNEUMOCYSTIS PNEUMONIA IN CHILDREN WITH ACQUIRED IMMUNODEFICIENCY SYNDROME

1994 ◽  
Vol 13 (1) ◽  
pp. 72-73 ◽  
Author(s):  
&NA;
2012 ◽  
Vol 136 (9) ◽  
pp. 1001-1003 ◽  
Author(s):  
Yi Zhou ◽  
Jayarama Shetty ◽  
Michael R Pins

A Pneumocystis jiroveci infection–associated mass clinically mimicking a malignancy (ie, pseudotumor) is rare and usually occurs in the lung in association with Pneumocystis pneumonia. Pneumocystis jiroveci pseudotumors of the small intestine are extremely rare and represent an unusual form of disseminated P jiroveci infection. We present a case of small-intestine P jiroveci pseudotumor as an acquired immunodeficiency syndrome–presenting illness in a patient with coinfection with cytomegalovirus, no pulmonary symptoms, and no known risk factors for human immunodeficiency virus infection. This case reinforces the potential importance of cytomegalovirus coinfection in the disseminated form of Pneumocystis infection and illustrates the importance of an expanded differential diagnosis when confronted with a clinically atypical mass lesion.


2018 ◽  
Vol 30 (1) ◽  
pp. 86-89 ◽  
Author(s):  
Moemi Okazaki ◽  
Masafumi Okazaki ◽  
Miho Nakamura ◽  
Tadashi Asagiri ◽  
Seisho Takeuchi

Both co-trimoxazole and pentamidine are used for the treatment of pneumocystis pneumonia (PCP) and are known to cause hypoglycemia as an adverse drug reaction. Here, we describe a rare case of a late-diagnosed female patient with acquired immunodeficiency syndrome (AIDS) who developed the first hypoglycemic attack as an adverse effect of co-trimoxazole, followed by a second hypoglycemic attack as an adverse effect of pentamidine. Physicians caring for patients with AIDS and PCP should be aware of possible hypoglycemia in patients with many risk factors.


Sign in / Sign up

Export Citation Format

Share Document